Your browser doesn't support javascript.
loading
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
Dávila Saldaña, Blachy J; John, Tami; Bonifant, Challice; Buchbinder, David; Chandra, Sharat; Chandrakasan, Shanmuganathan; Chang, Weni; Chen, Leon; Elfassy, Hannah L; Geerlinks, Ashley V; Giller, Roger H; Goyal, Rakesh; Hagin, David; Islam, Shahidul; Mallhi, Kanwaldeep; Miller, Holly K; Owen, William; Pacheco, Martha; Patel, Niraj C; Querfeld, Christiane; Quigg, Troy; Richard, Nameeta; Schiff, Deborah; Shereck, Evan; Stenger, Elizabeth; Jordan, Michael B; Heslop, Helen E; Bollard, Catherine M; Cohen, Jeffrey I.
Afiliación
  • Dávila Saldaña BJ; Department of Pediatrics, George Washington University, Washington, DC.
  • John T; Cell Enhancement and Technologies for Immunotherapy, Children's National Hospital, Washington, DC.
  • Bonifant C; Department of Pediatrics, Center for Cell and Gene Therapy, Texas Children's Hospital/Baylor College of Medicine, Houston, TX.
  • Buchbinder D; Department of Pediatrics, University of Michigan, Ann Arbor, MI.
  • Chandra S; Department of Hematology, Children's Hospital of Orange County, Orange, CA.
  • Chandrakasan S; Department of Pediatrics, University of California at Irvine, Orange, CA.
  • Chang W; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Chen L; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA.
  • Elfassy HL; Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School of Brown University, Providence, RI.
  • Geerlinks AV; Department of Pediatrics, George Washington University, Washington, DC.
  • Giller RH; Sacrée-Coeur of Montréal Hospital, University of Montréal, Montréal, QC, Canada.
  • Goyal R; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Hagin D; Pediatric Bone Marrow Transplant & Cellular Therapeutics Program, Children's Hospital Colorado/University of Colorado School of Medicine, Aurora, CO.
  • Islam S; Division of Hematology, Oncology, and Blood and Marrow Transplant, Children's Mercy Kansas City, Kansas City, MO.
  • Mallhi K; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel.
  • Miller HK; Department of Haematology, Waikato Hospital, Hamilton, New Zealand.
  • Owen W; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.
  • Pacheco M; Phoenix Children's Hospital, Phoenix, AZ.
  • Patel NC; Children's Cancer and Blood Disorders Center, Children's Hospital of the King's Daughters, Norfolk, VA.
  • Querfeld C; Pediatric Hematology/Oncology, Children's Health/University of Texas Southwestern, Dallas, TX.
  • Quigg T; Levine Children's Hospital, Atrium Health, Charlotte, NC.
  • Richard N; Division of Dermatology and Toni Stephenson Lymphoma Center, City of Hope and Beckman Research Institute, Duarte, CA.
  • Schiff D; Pediatric Blood and Marrow Transplantation Program, Methodist Children's Hospital, San Antonio, TX.
  • Shereck E; Children's Cancer and Blood Disorders Program, Randall Children's Hospital at Legacy Emanuel, Portland, OR.
  • Stenger E; Department of Pediatrics, University of California San Diego, La Jolla, CA.
  • Jordan MB; Division of Hematology-Oncology, Rady Children's Hospital, San Diego, CA.
  • Heslop HE; Division of Pediatric Hematology/Oncology, Oregon Health and Science University, Portland, OR.
  • Bollard CM; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA.
  • Cohen JI; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Blood Adv ; 6(2): 452-459, 2022 01 25.
Article en En | MEDLINE | ID: mdl-34670275

Texto completo: 1 Colección: 01-internacional Asunto principal: Infecciones por Virus de Epstein-Barr / Células T Asesinas Naturales / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans País/Región como asunto: America do norte / Asia Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Infecciones por Virus de Epstein-Barr / Células T Asesinas Naturales / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans País/Región como asunto: America do norte / Asia Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article